The Lung Research Center—part of the Brigham Research Institute—represents the research arm of BWH’s Lung Center, a medical and surgical collaboration between the Division of Thoracic Surgery and the Division of Pulmonary and Critical Care Medicine. Individually, these two specialties have been conducting life-changing lung research for years. United with the Channing Division of Network Medicine in the Lung Research Center, they offer patients with lung disease an interactive and collaborative biomedical powerhouse.
Our Harvard Medical School-affiliated physician scientists, led by Raphael Bueno, MD, Chief of Thoracic Surgery, Bruce Levy, MD, Chief of Pulmonary and Critical Care Medicine and Edwin Silverman, MD, Chief of the Channing Division of Network Medicine, unearth discoveries that impact the prevention, diagnosis and treatment of a host of diseases and conditions related to the lungs.
Recent studies have focused on lung injury and inflammation, lung cancer genetics, gender-specific cancer treatments, chronic obstructive pulmonary disease (COPD) and asthma, rare diseases such as lymphangioleiomyomatosis (LAM) and interstitial lung disease and much more. Collaboration among physicians and investigators is enhanced by detailed patient intake form that, when linked with an electronic medical record, simplifies flow between clinical practices while enabling biomedical research. Our lung research efforts heighten scientific understanding within the international medical community and directly translate to breakthrough care that benefits respiratory patients worldwide.
Recent and current lung research studies in the Lung Research Center focus on:
Lung Inflammation and Injury
The annual Lung Center Research Symposium and Poster Session at the Brigham Research Institute (BRI) highlights research activities at BWH and encourages cross-collaborative efforts among clinicians and researchers.
The New England Lung Conference featuring BWH lung experts shares research findings and exciting innovations in respiratory care.
Select patients have the opportunity to participate in investigational clinical trials that study the safety and effectiveness of new treatment approaches for specific diseases. Cancer patients have direct access to the latest research-based treatments and clinical trials through our role in the Dana-Farber/Harvard Cancer Center (DF/HCC), a National Cancer Institute-funded consortium.
Visit our clinical trials page for a list of all lung-related clinical trials open to new participants at Brigham and Women’s Hospital and other Partners HealthCare institutions. Only patients who have provided consent participate in studies.
Read BHW Clinical & Research News for the latest updates on discoveries and staff in lung care and research.
Learn how you can support our lung research.
Access current and past issues of Pulmonary Advances newsletter.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.